More Efforts Needed To Make Taiwan A Springboard To China – BioBusiness Asia Conference
This article was originally published in PharmAsia News
Cooperation is needed between pharma partners in addition to implementation of cross-strait agreements.
You may also be interested in...
Regulators from Japan and Taiwan met in late December to review prospects for convergence and pointed to manufacturing and new drug approvals as areas that were ripe for harmonization agreements.